International Journal of Epidemiology 2002;31:128-139
© International Epidemiological Association 2002
Special Theme: Systematic Reviews and Meta-Analysis |
Sources of variation of Helicobacter pylori treatment success in adults worldwide: a meta-analysis
a School of Public Health at Dallas, University of Texas—Houston, Health Science Center.
b School of Public Health, University of Texas—Houston, Health Science Center.
c Presbyterian Hospital of Dallas and The University of Texas Southwestern Medical Center at Dallas.
Lori Ann Fischbach, MPH Program at UT Southwestern, 5323 Harry Hines Blvd, V8.112, Dallas, TX 75390–9128, USA. E-mail: Lori.Fischbach{at}UTSouthwestern.edu
Abstract
Background A vast number of Helicobacter pylori treatment trials have been conducted. Regimens may vary in efficacy in different patient populations.
Methods We identified sources of treatment effect variation from 618 treatment groups using weighted cross-classified multi-level meta-regression models. Summary effect estimates were calculated within groups that lacked identified heterogeneity.
Results Overall, treatment was less successful with shorter treatment duration and dual drug (versus triple or quadruple drug) therapies. For nitroimidazole-based regimens, treatment was less successful in populations with frequent childhood H. pylori infection or metronidazole resistance and more successful in northeastern Asia. Non-nitroimidazole treatments of longer duration and those from less recent reports were most successful. Some one-week regimens—(nitroimidazole/ tetracycline/bismuth, ranitidine bismuth citrate/amoxicillin/clarithromycin, and clarithromycin/amoxicillin/proton pump inhibitor) were highly successful in northeastern Asia regardless of metronidazole resistance. The most successful regimen in populations with both a high prevalence of metrondiazole resistance and frequent infection in children (metronidazole/furazolidone/amoxicillin) eliminated fewer than 70% of infections.
Conclusions More effective treatments are needed for most populations of the world where H. pylori infection in children and drug resistance are common. Current treatment guidelines do not coincide with the best treatment regimens identified in this meta-analysis.
Keywords Helicobacter pylori, meta-analysis, review, treatments, drug resistance, prevalence, world health, review
Accepted 5 October 2001
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. Dailidiene, M. T. Bertoli, J. Miciuleviciene, A. K. Mukhopadhyay, G. Dailide, M. A. Pascasio, L. Kupcinskas, and D. E. Berg Emergence of Tetracycline Resistance in Helicobacter pylori: Multiple Mutational Changes in 16S Ribosomal DNA and Other Genetic Loci Antimicrob. Agents Chemother., December 1, 2002; 46(12): 3940 - 3946. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Egger, S. Ebrahim, and G. D. Smith Where now for meta-analysis? Int. J. Epidemiol., February 1, 2002; 31(1): 1 - 5. [Full Text] [PDF]
|
|